How long does norovirus last in adults
Pro Research Analysisby 
Searched over 200M research papers
Duration of Norovirus in Adults
Acute Norovirus Infection Duration
Norovirus is a leading cause of acute gastroenteritis, typically presenting with symptoms such as vomiting, diarrhea, and stomach pain. In otherwise healthy adults, the duration of acute norovirus infection is generally short. Most individuals experience symptoms for about 2 to 3 days, with a complete recovery within 3 to 5 days Green2014Lopman2004. This rapid resolution is characteristic of the self-limiting nature of the virus in healthy populations.
Prolonged Norovirus Shedding in Elderly and Immunocompromised Individuals
In contrast to the brief duration of symptoms in healthy adults, elderly individuals and those with compromised immune systems can experience prolonged viral shedding. Studies have shown that elderly patients can excrete the virus for an average of 14.3 days, with some cases extending up to 32 days . This extended period of viral shedding poses a significant risk for transmission, especially in semiclosed environments like aged-care facilities .
Chronic Norovirus Infection in Immunocompromised Hosts
Immunocompromised individuals, such as those who have undergone organ transplants or are receiving immunosuppressive therapy, can suffer from chronic norovirus infections. These infections can persist for weeks, months, or even years, making clinical management challenging. For instance, kidney transplant recipients have been documented to shed the virus for durations ranging from 97 to 898 days . Similarly, allogeneic hematopoietic stem cell transplant recipients have experienced diarrhea lasting a median of 3 months, with some cases extending up to 14 months . The persistence of the virus in these patients is often accompanied by continuous viral evolution, complicating treatment efforts .
Implications for Public Health and Clinical Management
The prolonged duration of norovirus infection and shedding in vulnerable populations underscores the need for stringent infection control measures, particularly in healthcare and aged-care settings. Monitoring viral loads and implementing isolation protocols can help mitigate the spread of the virus. Additionally, the development of effective vaccines and antiviral therapies remains a priority to protect these high-risk groups .
Conclusion
While norovirus typically causes a short-lived illness in healthy adults, the duration of infection can be significantly extended in elderly and immunocompromised individuals. Understanding these variations is crucial for effective public health strategies and clinical management to prevent widespread outbreaks and protect vulnerable populations.
Sources and full results
Most relevant research papers on this topic
Chronic norovirus infection after kidney transplantation: molecular evidence for immune-driven viral evolution.
Chronic norovirus infection may persist in adult kidney transplant recipients, with molecular analysis suggesting continuous viral evolution in immunocompromised patients unable to clear the infection.
DOI
Norovirus infection in immunocompromised hosts.
Chronic norovirus infection in immunocompromised individuals can last weeks to years, making clinical management difficult.
DOI
Clinical manifestation of norovirus gastroenteritis in health care settings.
Hospitalized patients experience a longer duration of norovirus gastroenteritis compared to nursing home staff and residents, highlighting the need for increased prevention measures in healthcare settings.
DOI
Viral shape-shifting: norovirus evasion of the human immune system
Noroviruses persist in human populations due to molecular and structural mechanisms that enable their evasion of the immune system, highlighting the need for effective vaccines and antiviral therapies.
Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity.
Norovirus gastroenteritis is a previously unrecognized cause of prolonged morbidity and mortality in adults after allogeneic hematopoietic stem cell transplantation.
DOI